Posted On: 05/19/2014 8:00:09 PM
Post# of 377
PPCH Recent News 0.1900 Monday, May 19, 2014 7:00:08 PM $PPCH
Propanc Health Group Targets Cancer Patient Trials in 2015
GlobeNewswire - Fri May 16, 3:00PM CDT
Propanc Health Group Corporation (OTCQB
PCH) ("Propanc Health Group," "Propanc" or "the Company"
, a developmental stage a healthcare company focused on new cancer treatments for patients with solid tumors, today announced its key strategic objectives for the development of its lead product, PRP. This Company is now refocusing the preferred route of administration to intravenous (I.V.) injection. They are now targeting 2015 to prepare for and initiate human trials in patients with advanced colorectal and/or pancreatic cancers.
Propanc Health Group Targets Cancer Patient Trials in 2015
GlobeNewswire - Fri May 16, 3:00PM CDT
Propanc Health Group Corporation (OTCQB
PCH) ("Propanc Health Group," "Propanc" or "the Company", a developmental stage a healthcare company focused on new cancer treatments for patients with solid tumors, today announced its key strategic objectives for the development of its lead product, PRP. This Company is now refocusing the preferred route of administration to intravenous (I.V.) injection. They are now targeting 2015 to prepare for and initiate human trials in patients with advanced colorectal and/or pancreatic cancers. 
(0)
(0)
